orungal kõvakapsel
johnson & johnson uab - itrakonasool - kõvakapsel - 100mg 4tk; 100mg 15tk
haloperidol-richter süstelahus
gedeon richter plc. - haloperidool - süstelahus - 5mg 1ml 1ml 5tk
haloperidol decanoate-richter süstelahus
gedeon richter plc. - haloperidool - süstelahus - 50mg 1ml 1ml 5tk
apel õhukese polümeerikattega tablett
medochemie limited - linesoliid - õhukese polümeerikattega tablett - 600mg 100tk; 600mg 20tk; 600mg 14tk; 600mg 10tk; 600mg 24tk; 600mg 60tk; 600mg 50tk; 600mg 30tk
linezolid sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - linesoliid - õhukese polümeerikattega tablett - 600mg 60tk; 600mg 30tk; 600mg 28tk; 600mg 10tk; 600mg 50tk; 600mg 100tk
linezolid krka infusioonilahus
krka, d.d., novo mesto - linesoliid - infusioonilahus - 2mg 1ml 300ml 1tk
linezolid fresenius kabi infusioonilahus
fresenius kabi polska sp. z o.o. - linesoliid - infusioonilahus - 2mg 1ml 300ml 50tk; 2mg 1ml 300ml 30tk; 2mg 1ml 300ml 10tk
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
linezolid norameda infusioonilahus
norameda uab - linesoliid - infusioonilahus - 2mg 1ml 300ml 5tk; 2mg 1ml 300ml 30tk
nelladel kaetud tablett
idelyn s.r.o. - taimsed preparaadid - kaetud tablett - 6,4mg 300mg 60tk; 6,4mg 300mg 30tk; 6,4mg 300mg 90tk